Developing & advancing new HP MRI technology to better
detect, understand, and treat human diseases worldwide
| |
2024 Highlights & 2025 Workshop Announcement | |
|
As we welcome the fall season, we are reflecting on 2024 and some of the great advances in HP C-13 MRI Technology accomplished over the past year. In this newsletter we highlight recent seminar presentations and present recent publication releases by the HMTRC in developing and advancing HP C-13 MR technology to better identify and understand human diseases and ultimately to improve patient care.
Also, announcing our 2025 HMTRC Workshop dates! See below for details! Registration and event details to be released Winter 2024.
Wishing you all a great fall season,
The HMTRC team & Collaborators
| |
|
Save-the-Date: HMTRC Workshop for
Hyperpolarized Carbon-13 MRI Technology Development
April 3rd-4th 2025, Pre-meeting Events April 2nd Afternoon
| |
The April 2025 Hyperpolarized Carbon-13 MRI Technology Development Workshop includes lectures, hands-on training and discussions on dissolution DNP methodology, polarizer instrumentation, MR Sequence and Acquisitions, Pre-clinical HP Chemistry Preps, Human HP Investigational Dose Formulation & Production, Clinical Translation Methods, Clinical Trial Research, and Analysis & Display Software. | |
The HMTRC Website. What's New? | |
Recently Released: HP C-13 MRI Seminar Presentations | |
HMTRC Recent Research Publications | |
Recent journal articles supported by the center
to inspire & drive your basic and clinical research
| | |
|
Dual hyperpolarized [1-13C]pyruvate and [13C]urea magnetic resonance imaging of prostate cancer | |
de Kouchkovsky I, Nguyen H, Chen HY, Liu X, Qin H, Stoher BA, Delos Santos R, Ohliger MA,Wang ZJ, Bok RA, Gordon JW, Larson PEZ, Frost M, Okamoto K, Gebrezgiabhier D, Cooperberg M, Vigneron DB, Kurhanewicz J, Aggarwal R
JMRO
October 2024
| |
A pharmacokinetic model for hyperpolarized 13C-pyruvate MRI when using metabolite-specific bSSFP sequence | |
Sahin S, Garnæs MF, Bennett A, Dwork N, Tang S, Liu X, Vaidya M, Wang ZJ, Larson PEZ
Magn Reson Med
October 2024
| |
| |
|
Protocol for producing hyperpolarized 13C-bicarbonate for clinical MRI of extracellular pH in aggressive tumors | |
Mu C, Liu X, Riselli A, Slater J, Escobar E, Dang D, Drapeau S, Delos Santos R, Andosca S, Nguyen H, Larson PEZ, Bok R, Vigneron DB, Kurhanewicz J, Wilson DM, Flavell RR
STAR Protoc
June 2024
| |
Detection of early-stage NASH using non-invasive hyperpolarized 13C metabolic imaging | |
von Morze C, Blazey T, Shaw A, Spees WM, Shoghi KI, Ohliger MA
Sci Rep
June 2024
| |
| |
|
Brain metabolism after therapeutic hypothermia for murine hypoxia-ischemia using hyperpolarized [1-13C] pyruvate magnetic resonance spectroscopy. | |
Liu X, Manninen T, Capper AM, Jiang X, Ellison J, Kim Y, Gurler G, Xu D, Ferriero DM
NMR Biomed
June 2024
| |
|
Call for Seminar Presenters
We are currently looking for presenters for our International HP C-13 MRI Seminar for November & December 2024. Present new findings, publications, or other work in preclinical and human research. Presentations are 25 minutes with a 5-minute Q&A. Email us at hyperpolarizedmri@ucsf.edu.
| |
(NIH P41EB013598) and focuses on the development and dissemination of new advances in dissolution DNP techniques and instrumentation, specialized data acquisition methodology, and analysis software for biomedical research.
| |
Copyright © 2020 HMTRC, All rights reserved. | | | | |
